Status:
UNKNOWN
Radiotherapy for Thoracic and Breast Cancer and the Related Cardiotoxicity Following Treatment (RACCOON)
Lead Sponsor:
Yonsei University
Conditions:
Patients Who Receive Thoracic Irradiation
Eligibility:
All Genders
20+ years
Brief Summary
The purpose of this study is to investigate the risk factors and mechanisms of cardiotoxicity following thoracic radiotherapy and to provide insights in preventing radiation-related cardiotoxicity. -...
Detailed Description
Cancer patients who undergo thoracic irradiation receive a certain amount of dose to the heart. Cardiotoxicity may occur in some patients several years after radiotherapy due to the late effect of rad...
Eligibility Criteria
Inclusion
- Patients with solid cancer who are subject to thoracic irradiation.
- Patients who are 20 years old or older
- Eastern Cooperative Oncology Group Performance Status Scale 0-2
- Patients with cognitive abilities to receive virtual reality information
Exclusion
- Patients with a history of previous thoracic irradiation
- Patients who refused consent
- Patients with a history of heart failure before radiotherapy
Key Trial Info
Start Date :
December 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04674501
Start Date
December 22 2020
End Date
December 1 2022
Last Update
December 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System
Seoul, South Korea